Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-10155.5China
BA.2.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used